Financial support and sponsorship This work was supported by National Institutes of Health grants R01 AG057381 (Ladiges and Darvas, co-PI's) and R01 AG057381 (Ladiges PI)
Improves gut health BPC-157 can reduce inflammation in the gut and promote the healing of damaged tissue in the stomach and intestines
6 (64), eabj3859
Selected reaction monitoring-based proteomics: workflows, potential, pitfalls and future directions
Roxadustat (FG-4592) versus epoetin alfa for anemia in patients receiving maintenance hemodialysis: a phase 2, randomized, 6-to 19-week, open-label, active-comparator, dose-ranging, safety and exploratory efficacy study
Quick Takeaways Human sleep trials used 25 nmol/kg IV for 7 consecutive nights The commonly used 100250 mcg subcutaneous protocol lacks direct clinical validation DSIP demonstrates an unusually wide safety margin in animal and human research Most evidence comes from small 1980s pilot studies, not modern RCTs What DSIP Actually Is (And Why Its Misunderstood) DSIP is a nine-amino-acid neuropeptide first isolated in 1977 from the cerebral venous blood of sleeping rabbits
